Institute of Aerospace Medicine (DLR) and Chair of Clinical Aerospace Medicine, University of Cologne, Germany; Department II of Internal Medicine, Divisions of Nephrology, Rheumatology, Diabetes and General Internal Medicine, University Hospital of Cologne, Germany; Department of Internal Medicine and Cardiology, Evangelisches Klinikum Köln Weyertal, Cologne; Department III of Internal Medicine, Cardiac Center, University Hospital of Cologne, Germany; University Hypertension Center, University of Cologne, Germany.
Dtsch Arztebl Int. 2018 Aug 20;115(33-34):557-568. doi: 10.3238/arztebl.2018.0557.
Essential arterial hypertension is one of the main treatable cardiovascular risk factors. In Germany, approximately 13% of women and 18% of men have uncontrolled high blood pressure (≥ 140/90 mmHg).
This review is based on pertinent publications retrieved by a selective literature search in PubMed.
Arterial hypertension is diagnosed when repeated measurements in a doctor's office yield values of 140/90 mmHg or higher. The diagnosis should be confirmed by 24-hour ambulatory blood pressure monitoring or by home measurement. Further risk factors and end-organ damage should be considered as well. According to the current European guidelines, the target blood pressure for all patients, including those with diabetes mellitus or renal failure, is <140/90 mmHg. If the treatment is well tolerated, further lowering of blood pressure, with a defined lower limit, is recommended for most patients. The main non-pharmacological measures against high blood pressure are reduction of salt in the diet, avoidance of excessive alcohol consumption, smoking cessation, a balanced diet, physical exercise, and weight loss. The first-line drugs for arterial hypertension include long-acting dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers, and thiazide-like diuretics. Mineralocorticoid-receptor blockers are effective in patients whose blood pressure cannot be brought into acceptable range with first-line drugs.
In most patients with essential hypertension, the blood pressure can be well controlled and the cardiovascular risk reduced through a combination of lifestyle interventions and first-line antihypertensive drugs.
原发性高血压是可治疗的心血管主要危险因素之一。在德国,约 13%的女性和 18%的男性血压控制不佳(≥140/90mmHg)。
本综述基于在 PubMed 中进行的选择性文献检索获得的相关出版物。
当医生办公室内的多次测量值≥140/90mmHg 时,即可诊断为高血压。应通过 24 小时动态血压监测或家庭测量来确认诊断。还应考虑其他危险因素和靶器官损害。根据目前的欧洲指南,所有患者(包括糖尿病或肾衰竭患者)的目标血压均应<140/90mmHg。如果治疗耐受良好,建议大多数患者进一步降压,同时确定一个较低的下限值。针对高血压的主要非药物措施包括减少饮食中的盐摄入、避免过量饮酒、戒烟、均衡饮食、体育锻炼和减肥。原发性高血压的一线药物包括长效二氢吡啶类钙通道阻滞剂、血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂以及噻嗪类利尿剂。对于血压不能用一线药物控制在可接受范围内的患者,可使用盐皮质激素受体阻滞剂。
在大多数原发性高血压患者中,通过生活方式干预和一线抗高血压药物的联合治疗,可以很好地控制血压并降低心血管风险。